Visceral fat and subcutaneous fat look identical on a bathroom scale but behave like two different organs. One sits under your skin and mostly just takes up space. The other wraps around your liver, pancreas, and intestines and pumps out hormones that raise your blood pressure, disrupt insulin signaling, and drive inflammation throughout your body.
- Subcutaneous fat sits under the skin and is largely cosmetic; visceral fat surrounds abdominal organs and is metabolically active.
- A waist circumference above 40 inches in men or 35 inches in women is the standard clinical flag for excess visceral fat.
- BMI can't distinguish between fat types at all — waist circumference and waist-to-hip ratio are used almost as often as BMI in primary care by 2026.
- A comprehensive metabolic panel, lipid panel, and fasting insulin or HbA1c expose metabolic activity a tape measure can only suggest.
- Visceral fat mobilizes faster than subcutaneous fat, responding well to caloric deficit, resistance training, and — when labs justify it — GLP-1 therapy.
- A normal BMI doesn't rule out dangerous visceral fat levels — the "TOFI" (thin outside, fat inside) pattern is real.
TL;DR
Visceral fat vs subcutaneous fat comes down to location and metabolic behavior: subcutaneous fat sits under the skin and is largely cosmetic, while visceral fat surrounds abdominal organs and is metabolically active, releasing free fatty acids and inflammatory cytokines that raise cardiovascular and diabetes risk. A waist circumference above 40 inches in men or 35 inches in women is the standard clinical flag for excess visceral fat, according to National Institutes of Health guidelines. Verdict: waist circumference and a comprehensive metabolic panel are the two fastest ways to know which type you're carrying, and reducing visceral fat responds well to structured medical support, not just calorie cutting. A clinician who reviews labs and builds a reduction plan will catch what a scale alone can't.
Why this matters
Two people can weigh the same 180 pounds and carry completely different health risk. One stores fat under the skin on the hips and thighs. The other stores it around the liver and intestines, even at a normal BMI — a pattern researchers call "TOFI," thin outside, fat inside.
Visceral fat is not inert padding. It's an endocrine organ that secretes resistin, leptin, and inflammatory markers like IL-6 and TNF-alpha directly into the portal vein, which feeds straight to the liver. That proximity is why visceral fat correlates so tightly with fatty liver disease, insulin resistance, and elevated triglycerides — subcutaneous fat on the same body might barely move the needle on those labs.
Visceral Fat vs. Subcutaneous Fat
How the two fat types actually differ
| Aspect | Subcutaneous Fat | Visceral Fat |
|---|---|---|
| Location | Under the skin | Surrounds abdominal organs (liver, pancreas, intestines) |
| Metabolic activity | Largely cosmetic, comparatively little independent metabolic risk | Metabolically active, secretes hormones and cytokines |
| Hormonal output | Minimal | Resistin, leptin, IL-6, TNF-alpha released directly into the portal vein |
| Associated health risk | Comparatively low | Fatty liver disease, insulin resistance, elevated triglycerides |
It's an endocrine organ that secretes resistin, leptin, and inflammatory markers like IL-6 and TNF-alpha directly into the portal vein, which feeds straight to the liver.
By 2026, waist circumference and waist-to-hip ratio are used almost as often as BMI in primary care because BMI can't distinguish between the two fat types at all. A bodybuilder and a sedentary office worker can share a BMI of 27 and have opposite risk profiles.
What you'll need
- A flexible tape measure (cloth, not metal) for waist circumference
- Access to lab work: a comprehensive metabolic panel, lipid panel, and fasting insulin or HbA1c
- A private space and 60 seconds for a proper waist measurement
- Optional: a DEXA scan or CT scan if your clinician wants a direct visceral fat volume reading
- A clinician who will actually interpret the numbers, not just log them
The steps
1. Measure your waist circumference correctly
Wrap the tape measure around your bare abdomen at the top of your hip bone, right after you exhale normally. Don't suck in your stomach — that skews the number low and hides risk. A reading above 40 inches in men or 35 inches in women signals elevated visceral fat regardless of total body weight, per NIH cardiovascular risk thresholds still in use in 2026. Common mistake: measuring at the belly button, which is often lower than the anatomical waist and produces a falsely reassuring number.
2. Calculate your waist-to-hip ratio
Divide waist circumference by hip circumference (measured at the widest point of the buttocks). A ratio above 0.90 in men or 0.85 in women points to central, visceral-pattern fat storage. This ratio matters more than BMI for cardiovascular risk because it captures distribution, not just mass. Common mistake: comparing your ratio to a friend's without accounting for frame size — the ratio is a risk signal, not a competition score.
3. Get a comprehensive metabolic panel and lipid panel
Blood work exposes what a tape measure can only suggest. Elevated fasting triglycerides, low HDL, and a triglyceride-to-HDL ratio above 3.0 are classic signatures of visceral fat's metabolic activity. A clinician who reads a comprehensive metabolic panel can flag early liver strain (elevated ALT/AST) that often shows up years before a diagnosis of fatty liver disease. Common mistake: treating a single normal panel as clearance — visceral fat markers shift with weight change and should be rechecked every 6 to 12 months.
A clinician who reads a comprehensive metabolic panel can flag early liver strain — elevated ALT/AST — that often shows up years before a diagnosis of fatty liver disease. Because visceral fat markers shift with weight change, panels should be rechecked every 6 to 12 months rather than treated as one-time clearance.
4. Check fasting insulin and HbA1c
Visceral fat is the primary driver of insulin resistance in most metabolic syndrome cases. Fasting insulin above roughly 10 uIU/mL alongside a normal glucose reading often indicates your pancreas is compensating for resistance that hasn't yet shown up as prediabetes. Common mistake: relying on glucose alone — glucose can stay normal for years while insulin climbs steadily in the background.
5. Consider imaging if the numbers don't add up
If waist circumference and labs both point to elevated visceral fat but the picture is unclear, a DEXA scan or abdominal CT can quantify visceral adipose tissue in square centimeters, giving a direct number instead of a proxy measurement. This step isn't necessary for most patients, but it's useful when body composition is genuinely ambiguous. Common mistake: ordering imaging as a first step instead of a last one — it's expensive and rarely changes the initial treatment plan.
6. Build a reduction plan around the mechanism, not the mirror
Visceral fat responds disproportionately well to a combination of caloric deficit, resistance training, and — when metabolic labs justify it — GLP-1 therapy, because it's more metabolically active and mobilizes faster than subcutaneous fat. Aerobic exercise at moderate intensity for 150 minutes a week has shown measurable visceral fat reduction independent of weight loss in multiple trials cited through 2026 clinical reviews. Common mistake: chasing spot reduction with ab exercises — crunches build muscle under the fat, they don't remove it.
Troubleshooting
- Waist measurement keeps changing day to day. Measure first thing in the morning, before eating or drinking, to reduce bloating variance.
- Weight is dropping but waist circumference isn't. This can mean you're losing subcutaneous fat and muscle while visceral fat lags — a sign to add resistance training and recheck insulin sensitivity.
- Labs look normal despite a large waist. Some patients carry visceral fat without yet showing lipid or glucose abnormalities; this is often an early window where intervention has the most leverage.
- BMI says "overweight" but you feel healthy. BMI can't separate fat type from muscle mass — waist-to-hip ratio and a metabolic panel review give a clearer answer.
- Insulin resistance markers are rising despite diet changes. Visceral fat loss often lags behind dietary changes by 8 to 12 weeks; don't judge progress before then. Review the mechanism in detail through how insulin resistance shows up in labs.
- You've tried general weight loss advice with no visceral-specific results. Generic calorie-counting apps don't account for the hormonal drivers behind central fat storage; a structured medical program targets the mechanism directly.
Fasting insulin above roughly 10 uIU/mL alongside a normal glucose reading often indicates your pancreas is compensating for resistance that hasn't yet shown up as prediabetes. Relying on glucose alone can be misleading — glucose can stay normal for years while insulin climbs steadily in the background.
Tools and resources
- Cloth tape measure for waist and hip circumference
- Lab panel: comprehensive metabolic panel, lipid panel, fasting insulin or HbA1c
- A clinician-guided program that reviews labs before recommending a plan, not after
- DEXA or CT imaging, reserved for ambiguous cases
- A resistance training routine, since muscle mass improves insulin sensitivity independent of fat loss
What to do next
Measuring your waist and getting labs drawn tells you where you stand today. The next step is a plan that actually targets visceral fat's hormonal drivers instead of generic weight loss advice. GoodLife Health builds that plan around your lab results — read how to choose a medical weight loss program built for exactly this kind of metabolic profile.
FAQ
What's the difference between visceral fat and subcutaneous fat? Subcutaneous fat sits directly under the skin and is largely cosmetic; visceral fat surrounds internal organs in the abdominal cavity and actively secretes inflammatory hormones that raise cardiovascular and metabolic risk.
Is visceral fat more dangerous than subcutaneous fat? Yes. Visceral fat is linked to insulin resistance, fatty liver disease, and elevated cardiovascular risk even in people at a normal BMI, while subcutaneous fat carries comparatively little independent metabolic risk.
How do I know if I have visceral fat? A waist circumference above 40 inches in men or 35 inches in women, combined with elevated triglycerides or fasting insulin, is the standard clinical signal for excess visceral fat in 2026 guidelines.
Can you lose visceral fat without losing subcutaneous fat? Visceral fat often mobilizes faster than subcutaneous fat during the first weeks of a caloric deficit or GLP-1 therapy, which is why waist circumference can shrink before overall body fat percentage changes much.
Does a CT scan or DEXA scan measure visceral fat directly? Yes, both can quantify visceral adipose tissue in square centimeters, but they're typically reserved for cases where waist circumference and lab markers don't align clearly.
How much does visceral fat raise diabetes risk? Visceral fat is the strongest fat-distribution predictor of insulin resistance and type 2 diabetes risk among common measurements, more predictive than total body fat percentage in most cardiometabolic studies through 2026.
Can exercise alone reduce visceral fat? 150 minutes of moderate aerobic exercise weekly has shown measurable visceral fat reduction in clinical trials, independent of total weight change, though pairing it with resistance training and dietary changes accelerates results.
Is waist circumference more useful than BMI for visceral fat? Yes. BMI can't distinguish fat distribution at all, while waist circumference and waist-to-hip ratio directly reflect central, visceral-pattern storage.
One last thing
A person can have a completely normal BMI and still carry dangerous levels of visceral fat — the "TOFI" pattern shows up in a meaningful share of normal-weight adults with fatty liver disease on imaging. The tape measure around your waist, not the number on the scale, is the number worth tracking in 2026.
Related guides
- Metabolic syndrome: what it is and how a doctor treats it
- How to choose a medical weight loss program
References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/